Clinical Trial Update: Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating camrelizumab plus apatinib in combination with GEMOX for locally advanced biliary tract cancer; the study is active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Apatinib (apatinib)
• Camrelizumab (camrelizumab)
• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Advanced Biliary Tract Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING